Overview
HR market data
Price History
HR price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.70 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.83 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 5.0% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -7.6% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $16.23 – $22.04 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $6.7B · P/B 1.30 · P/S 5.89.
Company News
RBC Capital Maintains Sector Perform on Healthcare Realty Trust, Raises Price Target to $22Benzinga · Aug 7, 2026, 7:33 PM
8-K filing — Healthcare Realty Trust Inc (HR)SEC EDGAR · Jul 31, 2026, 9:17 PM
Healthcare Realty Files Prospectus To Offer Up To $1B Of Class A Common StockBenzinga · Jul 31, 2026, 9:14 PM
Healthcare Realty Trust Files Prospectus For Offering Mixed Shelf; Terms UndisclosedBenzinga · Jul 31, 2026, 8:30 PM
Cantor Fitzgerald Maintains Overweight on Healthcare Realty Trust, Raises Price Target to $24Benzinga · Jul 31, 2026, 2:25 PM
Healthcare Realty Trust Q2 FFO $0.41 Beats $0.40 Estimate, Sales $281.849M Beat $274.580M EstimateBenzinga · Jul 30, 2026, 8:06 PM
Healthcare Realty Trust Raises FY2026 FFO Guidance from $1.59-$1.65 to $1.62-$1.66 vs $1.62 EstBenzinga · Jul 30, 2026, 8:00 PM
JP Morgan Maintains Neutral on Healthcare Realty Trust, Raises Price Target to $21Benzinga · Jul 9, 2026, 12:40 PM
UBS Maintains Neutral on Healthcare Realty Trust, Raises Price Target to $21Benzinga · Jul 8, 2026, 6:40 PM
Raymond James Reinstates Outperform on Healthcare Realty Trust, Announces $24 Price TargetBenzinga · Jun 17, 2026, 1:55 PM